Sizzling Technical Charts: Synthetic Biologics, Inc. (SYN), Energen Corporation (EGN)

Synthetic Biologics, Inc. (NYSE:SYN) recent decline occurred on low volume with 1.16 million contracts changing hands on 06-Dec-17. That’s down from its daily average of 1.25 million contracts. The first sale was made at $0.6 but later the stock became weaker, and closed with a fall of -2.24%. It was last traded at $0.61 apiece.

Synthetic Biologics, Inc. (SYN): Buy Candidate With 432.79% Upside Potential

Synthetic Biologics, Inc. is maintained at an average buy rating by 3 stock analysts, and there are at least 4.9% of shares outstanding that are currently legally short sold. The shares went down by -18.15% in value last month. Year-to-date it plunged -20.57%. Analysts are turning out to be more optimistic than before, with 3 of analysts who cover Synthetic Biologics, Inc. (NYSE:SYN) advice adding it to buy candidate list. Wall Street experts also assign a $3.25 price target on Synthetic Biologics, Inc., pointing towards a 432.79% rally from current levels. The stock is trading for about -42.31% less than its 52-week high.

SYN Retreats -7.31% In A Week

This company shares (SYN) so far managed to recover 47.73% since collapsing to its 52-week low. Over a month, it has seen its stock price volatility to stay at 7.33% while shortening the period to a week, volatility was 7.2%. The share price has yet to cross its 20 days moving average, floating at a distance of -9.95% and sits -23.62% lower versus its 50 days moving average. When looking at the past five sessions, the stock returned -7.31% losses and is down by -9.64% compared with its 200-day moving average of $0.6951. Also, Synthetic Biologics, Inc. (SYN) needs to overturn a -27.02% decrease it experienced over the past twelve months.

Energen Corporation (NYSE:EGN) Consensus Call At 2.1

As regular trading ended, Energen Corporation (EGN) stock brought in a -$2.07 drop to $52.87. The day started at a price of $54.61 but then traded as high as $54.65 before giving part of the gains back. As for this week, analysts appear content to stick with their neutral outlook with the consensus call at 2.1. Energen Corporation is given 6 buy-equivalent recommendations, 0 sells and 10 holds. The company shares sank -16.16% from their peak of $63.06 and now has a $5.14 billion market value of equity.

Energen Corporation Could Grow 24% More

EGN’s mean recommendation on Reuter’s scale improved from 2.14 thirty days ago to 2.15 now, which indicates a hold consensus from the analyst community. They see Energen Corporation (EGN) price hitting a mean target of $65.56 a share, meaning the stock still has potential that could lift the price another 24% Also, the recent close suggests the stock is underpriced by 66.45% compared to the most bullish target.

Energen Corporation (EGN) Returns -8.32% This Year

The company had seen its current volume reaching at 0.95 million shares in the last trade. That compares with the recent volume average of 0.99 million. At the close of regular trading, its last week’s stock price volatility was 2.54% which for the month reaches 2.93%. Energen Corporation dipped to as low as $52.67 throughout the day and has returned -8.32% in this year. At one point in the past year, the shares traded as low as $46.16 but has recovered 14.54% since then.

Previous articleHere is How To Play Bottom in BioMarin Pharmaceutical Inc. (BMRN), Agios Pharmaceuticals, Inc. (AGIO)
Next articleWhy You Should Not Give Up On Radius Health, Inc. (RDUS), Sociedad Quimica y Minera de Chile S.A. (SQM)?